SEC Form D filing

Lycia Therapeutics, Inc.

Biotech · Growth · Regulation D 506(b) · CA · Filed June 25, 2026

Offering amount: $75.0M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: June 25, 2026
Signature date: June 24, 2026
CIK: 0001806540

Summary

Auto-generated

Lycia Therapeutics, Inc. is raising $75M via 506(b) in California, anchoring growth stage. 'Therapeutics' clearly identifies a biotech operating company.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.